Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMERICA INC Director's Dealing 2021

Dec 10, 2021

35296_dirs_2021-12-10_ae560a75-9050-4ef6-b24a-20c40739d384.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMERICA INC (BRMA)
CIK: 0000073290
Period of Report: 2021-12-09

Reporting Person: Coste Catherine (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-12-09 Non-qualified stock option $4.46 A 25000 Acquired 2031-12-09 Common Stock (25000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 9100 Indirect

Footnotes

F1: Shares were purchased through spouse's investment account.

F2: Not applicable